DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2005

DUOPHARMA BIOTECH BHD

Quarterly report for the financial period ended

30/06/2005
Quarter2
Financial Year End31/12/2005
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2005


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/06/2005 
30/06/2004 
30/06/2005 
30/06/2004 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
26,487
20,127
48,692
39,502
2Profit/(loss) before tax
9,355
6,987
16,823
14,075
3Profit/(loss)
after tax and minority
interest
5,665
5,924
11,570
11,549
4Net profit/(loss) for
the period
5,665
5,924
11,570
11,549
5Basic earnings/(loss) per share (sen)
4.31
4.50
8.78
8.76
6Dividend per share (sen)
0.00
3.00
0.00
3.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

0.8500
0.8100

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NameDUOPHARMA BIOTECH BHD  
Stock Name DBIOTEC    
Date Announced29 Aug 2005  
CategoryFinancial Results
Reference NoCS-050823-66601